We had the pleasure of working for Gilead, an American pharmaceutical company. For them, we conducted two studies: a survey on the Italian institutional response to the Covid19 emergency, focusing on three regions with the involvement of hospital technical profiles (i) and the second, a prospective study on the impact of Covid19 on the company’s Corporate Social Responsibility (CSR) strategy. It was a very interesting experience, reinforced by the countless interviews collected and the prospective analysis of new recovery scenarios after the emergency.